Impaired human ovarian follicular fluid complement function in hereditary angioedema

Scandinavian Journal of Immunology

Volumn 51, Issue 1, 2000, Pages 104-108

  Perricone, R ^a   De Carolis, C ^a   Giacomello, F ^a   Giacomelli, R ^b   De Sanctis, G ^a   Fontana, L ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DISORDER; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; OVARY FOLLICLE FLUID; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADULT; ANGIONEUROTIC EDEMA; CASE-CONTROL STUDIES; COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; FEMALE; FOLLICULAR FLUID; HUMANS; OVARIAN CYSTS; OVARY; OVULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033978323     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00652.x     Document Type: Article

References (26)

1. 1 Lipner H. In: Knobil E, Neill J, eds. Mechanism of Mammalian Ovulation. New York: Raven Press, 1988:447-86.
2. 2 Perricone R, De Carolis C, Moretti C et al. Complement, complement activation and anaphylatoxins in human ovarian follicular fluid. Clin Exp Immunol 1990;82:359-62.
3. 3 Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of Cl-esterase. Am J Med 1963;35: 37-44.
4. 4 Rosen FS, Carache P, Pensky J et al. Hereditary angioeneurotic edema: two genetic variants. Science 1965;148:57-8.
5. 5 Fontana L, Perricone R, De Carolis C, Pizzolo JG, Casciani CU. Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects. Res Clin Lab 1989;19:51-8.
6. 6 Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976;84:580-93.
7. 7 Perricone R, Pasetto N, De Carolis C et al. Cystic ovaries in women affected with hereditary angioedema. Clin Exp Immunol 1992;90:401-4.
8. 8 Adams J, Franks S, Polson DW et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985;ii:1375-8.
9. 9 Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355-9.
10. 10 Perricone R, Moretti C, De Carolis C et al. Increased plasma B-endorphin levels in hereditary angioedema. Immunopharmacology 1989;18: 89-94.
11. 11 Rapp HJ, Borsos T. Molecular Basis of Complement Action. New York: Appleton-Century Crofts, 1970.
12. 12 Platts-Mills TAE, Ishizaka K. (1974) Activation of the alternative pathway of human complement by rabbit cells. J Immunol 1974;113:348-58.
13. 13 Mayer MM. Complement and complement fixation. In: Kabat EA, Mayer MM eds. Experimental Immunochemistry, 2nd edn. Springfield, IL: Charles C. Thomas Publishers, 1961:133-240.
14. 14 Takada Y, Arimoto Y, Mineda H, Takada A. Inhibition of the classical and alternative pathways by amino acids and their derivatives. Immunology 1978;34:509-13.
15. 15 Perricone R, Fontana L, De Carolis C, Carini C, Sirianni MC, Aiuti F. Evidence for activation of complement in patients with AIDS related complex (ARC) and/or lymphoadenopathy syndrome (LAS). Clin Exp Immunol 1987;70:500-7.
16. 16 Carini C, Perricone R, Fratazzi C, Fontana L, De Carolis C, D'Amelio R, Sirianni MC, Aiuti F. Complement activation is associated with the presence of specific human immunodeficiency virus (HTV) - anti-HIV immune complexes in patients with acquired immunodeficiency syndrome-related complex or lymphoadenopathy syndrome. Scand J Immunol 1989;30:347-53.
17. 17 Brown D, Hobart MJ. Complement and complement fixation test. In: Thompson RA ed. Techniques in Clinical Immunology. Oxford, UK: Blackwell Science Publishers, 1977:65-84.
18. 18 Martin A, Lachmann PJ, Halbwachs L, Hobart MJ. Hemolytic diffusion plate assays for factor B and D of the alternative pathway of complement activation. Immunochemistry 1976;13:317-24.
19. 19 Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunol Chem 1965;2:235-54.
20. 20 Scheidegger JJ. Une micromethode de l'immunoelectrophorese. Int Arch Allergy 1955;7:103-10.
21. 21 Arroyave CM, Tan EM. Detection of complement activation by counterimmunoelectrophoresis (CIE). J Immunol Methods 1976;13:101-12.
22. 22 Arroyave CM, Tan EM. Mechanism of complement activation by radiographie contrast media. Clin Exp Immunol 1977;29:89-94.
23. 23 Lachmann PJ, Hobart MJ, Aston WP. Complement technology. In: Weir DM ed. Handbook of Experimental Immunology, Vol. 1. Oxford, UK: Blackwell Science Publishers, 1974:1-17.
24. 24 Beers WH. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell 1975;6:379-86.
25. 25 Strickland S, Beers WH. Studies on the role of plasminogen activator in ovulation. Tn vitro response of granulosa cells to gonadotropins, cyclic nucleotides and prostaglandins. J Biol Chem 1976;251:5694-702.
26. 26 Zurlo JJ, Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril 1990;54:62-72.